CTRI/2020/06/025733
Not Yet Recruiting
Phase 1
Clinical evaluation of the therapeutic efficacy of sarvakalpa ghan vati in non alcoholic liver disorder
Dr Zeba Malik0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Health Condition 1: K768- Other specified diseases of liver
- Sponsor
- Dr Zeba Malik
- Status
- Not Yet Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Clinical sign and symptoms suggesting of Yakrit Roga that is pain in right upper quadrant of stomach, Nausea, Vomiting, Loss of appetite and burning sensation in abdomen.
- •2\. USG abdomen showing fatty infiltration of the liver.
- •3\. LFT showing raised alanine transaminases.
Exclusion Criteria
- •1\. history of alcohol intake.
- •2\. Patients with positive markers of other liver diseases such as viral hepatitis, auto immune hepatitis, wilsons disease, alpha 1 antitrypsin deficiency.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Ayurvedic Management Of Hepatitis BHealth Condition 1: K739- Chronic hepatitis, unspecifiedCTRI/2018/05/014023Patanjali Ayurveda College50
Not Yet Recruiting
N/A
To evaluate the efficacy of Sarvakalpa-ghan-vati in management of non-alcoholic liver disorder.Health Condition 1: K77- Liver disorders in diseases classified elsewhereCTRI/2020/07/026362Patanjali Research Institute
Completed
N/A
An investigation of the clinical effectiveness of fixing the probe to the skin during ultrasound-guided central venous cannulation.Patients undergoing central venous cannulationJPRN-UMIN000009237Hirosaki University Graduate School of Medicine280
Not Yet Recruiting
Phase 2
Dashang aerosol spray in operated piles pain managementCTRI/2022/06/043585PARUL INSTITUTE OF AYURVEDA
Completed
N/A
Clinical evaluation of the efficacy and safety of Hochuekkito for fatigue in patients with myeloproliferative neoplasmsmyeloproliferative neoplasmsJPRN-UMIN000031519Department of Hematology, Juntendo University School of Medicine110